No survival improvement in patients with high-risk multiple myeloma harbouring del(17p) and/or t(4;14) over the two past decades.
Chalopin T, Vallet N, Theisen O, Ochmann M, Tiab M, Godmer P, Barin C, Hérault O, Gyan E, Le Gouill S, Avet-Loiseau H, Benboubker L, Moreau P, Touzeau C.
Chalopin T, et al. Among authors: vallet n.
Br J Haematol. 2021 Aug;194(3):635-638. doi: 10.1111/bjh.17488. Epub 2021 Apr 29.
Br J Haematol. 2021.
PMID: 33928635
No abstract available.